- Global Pharma News & Resources

Bioabsorbable Stents Market global sales are expected to experience modest CAGR of 6.1% between 2023 to 2032 | insightSLICE

According to estimates, the market for Bioabsorbable Stents would be worth US$ 285 million in 2021 and expand at a 6.1% CAGR from 2023 to 2032.

These coronary stents can entirely dissolve in the body and are also known as bioresorbable stents (BRS) or vascular platforms. In percutaneous coronary intervention (PCI) procedures, these biodegradable stents are used to provide initial support to the treated arteries and prevent severe recoiling and restenosis. Heart conditions are typically treated with bioabsorbable stents.

Access the sample report:

Global Bio-absorbable Stents Market Key Segments:

By Material Type

  • Polymeric Stents
  • Metallic Stents
  • Iron
  • Zinc
  • Magnesium

By Application Type

  • Coronary Artery Disease
  • Peripheral Artery Disease

By End-User Type

  • General Hospitals
  • Cardiac Centers
  • Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC
  • Middle East & Africa
    • UAE
    • South Africa
    • Saudi Arabia
    • Rest of MEA
  • South America
    • Brazil
    • Rest of South America

Bioabsorbable insert stents may have a role in the therapy of susceptible plaque by acting as a conduit for substances like medications and genes. Generally speaking, a stent embed is used to address abnormal heart diseases, like blocked veins.

Additionally, stents are implanted in the throat of patients with esophageal malignant development to allow the passage of food and liquids. Additionally, they are inserted in the ureter to prevent obstruction of the body’s waste stream leaving the kidney, and in the gall bladder to allow passage of bile in people with gall bladder disease and the middle and gastrointestinal tract.

A special kind of stent called a bio-absorbable stent is one that can dissolve or be reabsorbed by the patient’s body.

Bioabsorbable stents were created using materials that are easily absorbed by the body and perform the function of a stent that prevents barriers. These stents were developed after several problems with metal stents were researched.

The most common metal compounds used in the production of metallic bioabsorbable stents are iron and magnesium. Their solubility and state change after insertion are factors that determine these metal alloys’ biocompatibility.

Because magnesium is an essential part of the human body, magnesium bioabsorbable stents are among the most often used metallic compound stents in disease management.

It reduces thrombogenicity and triggers rapid endothelialization. Compared to iron-based bioabsorbable stents, magnesium-based stents have a shorter corruption time of two to three months.

Bioabsorbable stents can help patients avoid the lack of normal vasomotion, provide vessel reconstruction, and steadily increase endothelial function.

The key players of the Global Bio-absorbable Stents Market are:

Abbott Laboratories, Amaranth Medical Inc., Biotronik SE & Co. KG, Arterius Limited, ICON Interventional Systems, Elixir Medical Corporation, Reva Medical, S3V Vascular Technologies, Tepha, Inc., and Zorion Medical.

Read more about the report inclusions:

The market for Bioabsorbable Stents: Growth Drivers

The COVID-19 impact, which had earlier culminated in strict prevention strategies including social withdrawal, remote work, and the cessation of commercial activities that led to operational issues, is largely to blame for the rise as businesses resume operations and adjust to the new normal.

The growing number of elderly people who are at risk for coronary artery diseases and the adoption of poor lifestyle practices, which raises this risk.

Drug-eluting stents (DES), as opposed to bare-metal stents, have been shown in clinical trials to drastically reduce in-stent restenosis (BMS). Following DES implantation, the possibility of late stent thrombosis is still a substantial issue. Because of this, it is predicted that the market for bioabsorbable stents would soon begin to decline gradually.

The market for bioabsorbable stents is expanding as a result of several key causes, including a rapidly expanding geriatric population, medical tourism for new therapies, and rapidly improving healthcare infrastructure.

Regional performance of Bio-absorbable Stents Market

According to estimates, the global market for bioabsorbable stents is dominated by North America, which is followed by Europe. The primary factors supporting the market’s growth are thought to be the growing senior population and bad lifestyle choices.

The Asia Pacific region, however, is expected to experience the fastest growth during the predicted time period.

Related reports:

Global Positron Emission Tomography (PET) Systems Market:

Global Glaucoma Surgery Devices Market:

The leading market segments of Global Bio-absorbable Stents Market

In 2020, the coronary artery infection market segment led and held the largest market share. The market has developed as a result of the growing patient population and the prevalence of overweight people. Additionally, the mechanical development of drug-eluting bioabsorbable stents has increased their use in coronary artery disease.

In the year 2020, the polymer category dominated the market and maintained the largest market share. The human body generally breaks down the polymer-based covering. It quickly absorbs into the arteries, breaking the cycle and lowering problems.

In 2020, the hospital sector dominated the market and accounted for the largest market share. Due to the strict safety and control during the COVID-19 outbreak, the clinics see more people seeking treatment for cardiac diseases.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 10-Nov-2022